Ex vivo Vitamin D supplementation improves viscoelastic profiles in prostate cancer patients
- 7 June 2022
- journal article
- research article
- Published by IOS Press in Clinical Hemorheology and Microcirculation
- Vol. 81 (3), 221-232
- https://doi.org/10.3233/ch-211353
Abstract
BACKGROUND: Increased risk of thromboembolic events is associated with prostate cancer, specifically linked to activation of tissue factor. Vitamin D has potential anticoagulant effects by the downregulation of tissue factor expression. OBJECTIVES: TKeywords
This publication has 43 references indexed in Scilit:
- Thromboembolic Events Following Surgery for Prostate CancerEuropean Urology, 2012
- Vitamin D, Thrombosis, and Hemostasis: More than Skin DeepSeminars in Thrombosis and Hemostasis, 2012
- What Do Prostate Cancer Patients Die Of?The Oncologist, 2011
- Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe SwedenThe Lancet Oncology, 2010
- Vitamin D and prostate cancer risk: a review of the epidemiological literatureProstate Cancer and Prostatic Diseases, 2009
- Multi-institutional Study of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism in Prostate Cancer Patients Undergoing Laparoscopic or Robot-Assisted Laparoscopic Radical ProstatectomyEuropean Urology, 2008
- Prothrombotic effect of prostasomes of metastatic cell and seminal originThe Prostate, 2007
- Tissue factor mediates inflammationArchives of Biochemistry and Biophysics, 2005
- Human prostate cancer risk factorsCancer, 2004
- Vitamin D and Prostate CancerExperimental Biology and Medicine, 1999